Tags : Novel Tau Imaging Agent

Eisai Signs a Research Agreement with Cerveau Technologies for its

Shots: Eisai & Cerveau Technologies enter into a research collaboration to utilize Cerveau’s [F-18]MK-6240 in PET scan for assessing the status of neurofibrillary tangles (NFTs) in the brain The focus of the collaboration is to utilize Cerveau’s [F-18]MK-6240 as a biomarker and to evaluates its effect in Eisai’s neurodegenerative research studies Cerveau’s MK-6240 is a […]Read More